Article
Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
Cancer science - 1 Feb 2023
Wang Haiyong, Wu Shuangxiu, Li Zhenzhen, Zhang Chenyue, Shang Xiaoling, Zhao Chenglong, Li Zhenxiang, Lin Jiamao, Guo Jun, Wang Zhehai
Abstract excerpt
Small-cell lung cancer (SCLC) is an exceptionally lethal malignancy characterized by extremely high alteration rates and tumor heterogeneity, which limits therapeutic options. In contrast to non-small-cell lung cancer that develops rapidly with precision oncology, SCLC still remains outside the realm of precision medicine. No recurrent and actionable mutations have been detected. Additionally, a paucity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
